Who owns Protalix Biotherapeutics Inc?
- Ticker: PLX
- CUSIP Number: 74365a309
Tip: Access positions for across all investors
Analyze quarterly positions in Protalix Biotherapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Protalix Biotherapeutics stock
Who bought or sold Protalix Biotherapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BlackRock | 3.6M | $6.6M | 3% | Dec 2025 |
|
| Opaleye Management | 2.5M | $4.5M | -4% | Dec 2025 |
|
| Renaissance Technologies | 1.3M | $2.3M | -4% | Dec 2025 |
|
| Northern Trust | 866k | $1.6M | -4% | Dec 2025 |
|
| Geode Capital Management | 830k | $1.5M | 1% | Dec 2025 |
|
| State Street Corporation | 585k | $1.1M | 17% | Dec 2025 |
|
| Stratos Wealth Partners | 500k | $900k | 0% | Dec 2025 |
|
| Vanguard Group | 489k | $879k | 5% | Dec 2025 |
|
| Jane Street | 290k | $522k | 694% | Dec 2025 |
|
| Goldman Sachs Group | 263k | $473k | 74% | Dec 2025 |
|
| UBS Group | 263k | $473k | 38% | Dec 2025 |
|
| Connor, Clark & Lunn Investment Management | 232k | $418k | -42% | Dec 2025 |
|
| Main Street Financial Solutions | 214k | $385k | 66% | Dec 2025 |
|
| Bank of New York Mellon | 211k | $380k | 52% | Dec 2025 |
|
| Bridgeway Capital Management | 189k | $420k | 0% | Sep 2025 |
|
| Charles Schwab Investment Management | 175k | $315k | 0% | Dec 2025 |
|
| Commonwealth Equity Services | 172k | $309k | 0% | Dec 2025 |
|
| Evergreen Capital Management | 171k | $308k | 0% | Dec 2025 |
|
| Round Rock Advisors | 155k | $279k | 100% | Dec 2025 |
|
| Diametric Capital | 139k | $250k | -23% | Dec 2025 |
|
| Barclays | 113k | $203k | 11% | Dec 2025 |
|
| Wolverine Trading | 103k | $223k | 128% | Sep 2025 |
|
| Nuveen | 90k | $162k | 0% | Dec 2025 |
|
| Wells Fargo & Company | 79k | $142k | 84% | Dec 2025 |
|
| Lazard Asset Management | 71k | $129k | 100% | Dec 2025 |
|
| Hrt Financial | 65k | $116k | 100% | Dec 2025 |
|
| Orin Green Financial | 61k | $111k | 0% | Dec 2025 |
|
| Citadel Advisors | 53k | $118k | 401% | Sep 2025 |
|
| Invesco | 51k | $91k | 12% | Dec 2025 |
|
| Springbok Capital Management | 50k | $111k | -11% | Sep 2025 |
|
| Rhumbline Advisers | 44k | $80k | -32% | Dec 2025 |
|
| Two Sigma Securities | 40k | $72k | 100% | Dec 2025 |
|
| Susquehanna International | 39k | $69k | -64% | Dec 2025 |
|
| XTX Topco | 34k | $62k | -60% | Dec 2025 |
|
| Mirae Asset Global Etfs Holdings | 33k | $60k | 3% | Dec 2025 |
|
| Intech Investment Management | 31k | $56k | 0% | Dec 2025 |
|
| New York State Common Retirement Fund | 31k | $56k | -25% | Dec 2025 |
|
| Jpmorgan Chase & Co | 30k | $67k | 100% | Sep 2025 |
|
| Dimensional Fund Advisors | 29k | $52k | 69% | Dec 2025 |
|
| Aptus Capital Advisors | 27k | $48k | 3% | Dec 2025 |
|
| Capital Performance Advisors | 26k | $47k | 0% | Dec 2025 |
|
| Smartleaf Asset Management | 26k | $45k | 100% | Dec 2025 |
|
| Alaska Retirement Management Board | 22k | $39k | 100% | Dec 2025 |
|
| Marshall Wace | 19k | $34k | 100% | Dec 2025 |
|
| Police & Firemen's Retirement System of New Jersey | 19k | $33k | 0% | Dec 2025 |
|
| Manufacturers Life Insurance Company | 19k | $33k | -23% | Dec 2025 |
|
| SG Americas Securities | 17k | $31k | 100% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 17k | $31k | 12% | Dec 2025 |
|
| Lido Advisors | 16k | $35k | 0% | Dec 2025 |
|
| R Squared | 15k | $26k | 100% | Dec 2025 |
|
| ProShare Advisors | 13k | $24k | 10% | Dec 2025 |
|
| Altshuler Shaham | 12k | $22k | 0% | Dec 2025 |
|
| Cascade Financial Partners | 12k | $22k | -29% | Dec 2025 |
|
| Alliancebernstein | 12k | $26k | 0% | Sep 2025 |
|
| Equitable Holdings | 11k | $20k | 100% | Dec 2025 |
|
| Two Sigma Advisers | 10k | $23k | 100% | Sep 2025 |
|
| LPL Financial | 10k | $19k | 0% | Dec 2025 |
|
| Harbour Investment Management | 10k | $18k | 0% | Dec 2025 |
|
| Kestra Advisory Services | 10k | $18k | -9% | Dec 2025 |
|
| Russell Investments | 7.3k | $13k | -3% | Dec 2025 |
|
| Legal & General Group | 7.2k | $13k | -7% | Dec 2025 |
|
| Summit Investment Advisors | 7.1k | $13k | 0% | Dec 2025 |
|
| Tower Research Capital | 6.2k | $11k | 13% | Dec 2025 |
|
| TD Waterhouse Canada | 6.0k | $11k | 0% | Dec 2025 |
|
| California State Teachers Retirement System | 4.4k | $8.0k | 2% | Dec 2025 |
|
| Amalgamated Bank | 2.3k | $4.0k | -5% | Dec 2025 |
|
| Advisor Group Holdings | 1.2k | $2.2k | 71% | Dec 2025 |
|
| Royal Bank of Canada | 1.1k | $2.2k | 266% | Sep 2025 |
|
| Investment Research & Advisory Group | 1.0k | $1.8k | 0% | Dec 2025 |
|
| Deutsche Bank Aktiengesellschaft | 846.00 | $1.5k | -99% | Dec 2025 |
|
| Sterling Capital Management | 453.00 | $814.992300 | 168% | Dec 2025 |
|
| FMR | 438.00 | $972.009600 | 100% | Sep 2025 |
|
| GAMMA Investing | 355.00 | $639.000000 | 100% | Dec 2025 |
|
| Activest Wealth Management | 300.00 | $540.000000 | 0% | Dec 2025 |
|
| Federation des caisses Desjardins du Quebec | 250.00 | $450.000000 | 0% | Dec 2025 |
|
| Y.D. More Investments | 220.00 | $382.998000 | 0% | Dec 2025 |
|
| CWM | 203.00 | $0 | 25% | Dec 2025 |
|
| SRS Capital Advisors | 39.00 | $70.999500 | -87% | Dec 2025 |
|
| Pnc Financial Services | 20.00 | $36.000000 | -43% | Dec 2025 |
|
| SBI Securities | 1.00 | $2.000000 | -100% | Dec 2025 |
|
Who sold out of Protalix Biotherapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Two Sigma Investments | Jun 2025 | 72k | $106k |
| State of Wyoming | Sep 2025 | 39k | $87k |
| Virtu Financial | Sep 2025 | 17k | $37k |
| Simplex Trading | Sep 2025 | 2.9k | $6.0k |
| Truvestments Capital | Sep 2025 | 2.5k | $5.5k |
| Steward Partners Investment Advisory | Sep 2025 | 25.00 | $56.000000 |